Christopher Oreilly News Today

ALSTEAD — A local charter school has filed for bankruptcy and announced its closure, according to documents in federal court and a letter to its community members.

Takeda TOKYO4502NYSETAK today announced financial results for the third quarter of fiscal year 2023 period ended December 31 2023. With yeartodate strong momentum in its Growth Launch Products 12.7 at CER offsetting the significant revenue impact of generic entrants Takeda remains on track towards its fullyear Management Guidance.

Two New U.S. FDA Approvals in FY2023 Q3: FRUZAQLA for Adults With Previously Treated Metastatic Colorectal Cancer and ADZYNMA for Ultra-Rare Blood Clotting Disorder cTTPStrong Commercial Execution Maximizing Value of Existing Portfolio:ENTYVIO® Pen Launched in U.S. for Ulcerative Colitis; U.S. FDA Approval Decision...

A soup run in Dublin has described a €10,000 donation by Conor McGregor as “just incredible” ahead of Christmas.

Why anyone would be “angered” by a UN call for a ceasefire in the Middle East war is perplexing.

Christopher OReilly: Thank you very much for joining us out of your busy schedule today for the earnings call for Second Quarter Fiscal 2023 with Takeda Pharmaceutical Company Limited.

EQSAdhoc Takeda Pharmaceutical Company Limited Key word Forecast Takeda Pharmaceutical Company Limited Notice of the Revised Forecast of Consolidated Financials for FY2023 26Oct2023 0800 CETCEST Disc

EQS-Ad-hoc: Takeda Pharmaceutical Company Limited / Key word: Forecast Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for...

Takeda TOKYO4502NYSETAK today announced financial results for the first half of fiscal year 2023 six months ended September 30 2023 updating reported and Core forecasts and reconfirming Management Guidance for Core change at CER.

Takeda TOKYO4502NYSETAK today announced strong financial results for the first quarter of fiscal year 2023 period ended June 30 2023.